Table 3.
% of Participants | |||
---|---|---|---|
With Binocular Summation (BiS >1.1) |
With Binocular Inhibition (BiS <0.9) |
||
ETDRS letters | |||
Strabismic participants | 7 | 5 | |
Control participants | 10 | 0 | |
P value | .80 | .10 | |
2.5% Sloan letters | |||
Strabismic participants | 25 | 16 | |
Control participants | 75 | 0 | |
P value | <.001 | <.001 | |
1.25% Sloan letters | |||
Strabismic participants | 21 | 44 | |
Control participants | 64 | 11 | |
P value | <.001 | <.001 | |
Pelli-Robson CS | |||
Strabismic participants | 9 | 3 | |
Control participants | 0 | 12 | |
P value | .10 | .10 | |
Sweep VEP CS | |||
Strabismic participants | 32 | 49 | |
Control participants | 36 | 46 | |
P value | .70 | .90 |
Abbreviations: BiS, binocular summation score; CS, contrast sensitivity; ETDRS, Early Treatment Diabetic Retinopathy Study; VEP, visual evoked potential.
Binocular summation score calculated as a ratio between the binocular letter score and the better-eye letter score for the ETDRS and 2.5% and 1.25% Sloan letter charts. For the Pelli-Robson CS and sweep VEP CS tests, the BiS was calculated as a ratio between the better-eye CS score and the binocular CS score.
P values calculated by 2-tailed Fisher exact test.